Replies to post #336660 on Innovation Pharmaceuticals Inc (IPIX)

[frenchbroad]

The first person in this list is a super good reason to not be worry about Ipix future. https://www.ipharminc.com/scientific-advisors

[MackG]

I'm beginning to lose patience, but not faith. It will all come together.

[jav0033]

Welcome to the IPIX Board where there’s always that next Monday.

2020 has gone by and vaccines are already released with 94% effectivity here in the US.

Only one person has gone richer by $400K and that’s Leo.

[olden_grumpini]

I'm holding at this point in the hopes for a pop on a good PR and will sell a portion of my position.

I cannot put on blinders and ignore the amount of dilution waiting in the wings. I also cannot put on blinders as to the validity of the RBL testing. Imo the results of the RBL testing are not clinically reproducible. The testing was done at a concentration of 10µM which equates to an IV dose of 0.78 mg/kg. As we saw from the ABSSSI P-2b presentation in 2015, a single dose of 0.80 mg/kg resulted in hypertension >160 mmHg in 17% of the subjects. Given that the clinical trial is supposed to treat hospitalized patients already in respiratory distress (where elevated blood pressure is a problem) this is a big red flag imo. I expect they will use a significantly lower dose and that will reduce efficacy.

But given the market cap <$60m a well-written PR could pop the stock.

I invested in this company because of kevetrin.